JP2022513933A5 - - Google Patents
Info
- Publication number
- JP2022513933A5 JP2022513933A5 JP2021534641A JP2021534641A JP2022513933A5 JP 2022513933 A5 JP2022513933 A5 JP 2022513933A5 JP 2021534641 A JP2021534641 A JP 2021534641A JP 2021534641 A JP2021534641 A JP 2021534641A JP 2022513933 A5 JP2022513933 A5 JP 2022513933A5
- Authority
- JP
- Japan
- Prior art keywords
- disorders
- compound according
- disorder
- status epilepticus
- salt form
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862780703P | 2018-12-17 | 2018-12-17 | |
| US62/780,703 | 2018-12-17 | ||
| PCT/US2019/066923 WO2020131918A1 (en) | 2018-12-17 | 2019-12-17 | Organic compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513933A JP2022513933A (ja) | 2022-02-09 |
| JP2022513933A5 true JP2022513933A5 (cg-RX-API-DMAC7.html) | 2022-12-23 |
| JP7645797B2 JP7645797B2 (ja) | 2025-03-14 |
Family
ID=71100855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534641A Active JP7645797B2 (ja) | 2018-12-17 | 2019-12-17 | 有機化合物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12325726B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3897656A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7645797B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102931436B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113226326B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019406803B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021011765A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3121636A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL283960B2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021007142A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020131918A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10562930B1 (en) | 2018-08-31 | 2020-02-18 | Praxis Precision Medicines, Inc. | Salts and crystal forms of GABAA positive allosteric modulator |
| US12325726B2 (en) | 2018-12-17 | 2025-06-10 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2021168106A1 (en) * | 2020-02-18 | 2021-08-26 | Praxis Precision Medicines, Inc. | Deuterated neurosteroid |
| US20230416300A1 (en) * | 2020-08-20 | 2023-12-28 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2023159094A2 (en) * | 2022-02-16 | 2023-08-24 | Praxis Precision Medicines, Inc. | PROCESS OF MAKING 3α-HYDROXY-3β-METHOXYMETHYL-21-(1'- IMIDAZOLYL)-5α-PREGNAN-20-ONE |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5232917A (en) | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| DK1038880T3 (da) | 1994-02-14 | 2008-03-03 | Euro Celtique Sa | Androstaner og pregnaner til allosterisk modulering af GABA-receptor |
| US5939545A (en) | 1994-02-14 | 1999-08-17 | Cocensys, Inc. | Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series |
| KR100477070B1 (ko) * | 1994-03-25 | 2006-04-21 | 이소테크니카 인코포레이티드 | 중수소화작용에의한의약품의효능강화법 |
| UA73736C2 (en) * | 1999-04-29 | 2005-09-15 | Euro Celtic S A | Method for alleviating or preventing insomnia and inducing anesthesia |
| WO2005105822A2 (en) | 2004-04-23 | 2005-11-10 | Euro-Celtique S.A. | 3-alpha-hydroxy 21-n- heteroaryl-pregnane derivatives for modulation of brain excitability and a process for the production thereof |
| US20060074059A1 (en) * | 2004-08-26 | 2006-04-06 | Goliber Philip A | Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one |
| DK2168585T3 (da) * | 2005-06-09 | 2012-02-27 | Euro Celtique Sa | Farmaceutiske sammensætninger af en neuroaktiv steroid og anvendelser deraf |
| SMT202100509T1 (it) | 2013-04-17 | 2021-11-12 | Sage Therapeutics Inc | Steroide di c21-n-pirazolile 19-nor c3,3-disostituito per l'uso in terapia |
| MY190408A (en) * | 2014-10-16 | 2022-04-21 | Sage Therapeutics Inc | Compositions and methods for treating cns disorders |
| US20170233433A1 (en) * | 2014-10-16 | 2017-08-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| CN105985396A (zh) * | 2015-02-16 | 2016-10-05 | 苏州泽璟生物制药有限公司 | 氘代鹅去氧胆酸衍生物以及包含该化合物的药物组合物 |
| DK3258939T3 (da) | 2015-02-20 | 2022-12-12 | Sage Therapeutics Inc | Neuroaktive steroider, sammensætninger og anvendelser heraf |
| US20200291059A1 (en) | 2017-12-08 | 2020-09-17 | Sage Therapeutics, Inc. | Compositions and methods for treating cns disorders |
| US12325726B2 (en) | 2018-12-17 | 2025-06-10 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US20230416300A1 (en) | 2020-08-20 | 2023-12-28 | Intra-Cellular Therapies, Inc. | Organic compounds |
-
2019
- 2019-12-17 US US17/415,667 patent/US12325726B2/en active Active
- 2019-12-17 CA CA3121636A patent/CA3121636A1/en active Pending
- 2019-12-17 BR BR112021011765-2A patent/BR112021011765A2/pt unknown
- 2019-12-17 KR KR1020217022377A patent/KR102931436B1/ko active Active
- 2019-12-17 JP JP2021534641A patent/JP7645797B2/ja active Active
- 2019-12-17 MX MX2021007142A patent/MX2021007142A/es unknown
- 2019-12-17 CN CN201980083634.9A patent/CN113226326B/zh active Active
- 2019-12-17 IL IL283960A patent/IL283960B2/en unknown
- 2019-12-17 WO PCT/US2019/066923 patent/WO2020131918A1/en not_active Ceased
- 2019-12-17 EP EP19899589.6A patent/EP3897656A4/en active Pending
- 2019-12-17 AU AU2019406803A patent/AU2019406803B2/en active Active